Leiden University Scholarly Publications

Patients' and healthcare professionals' perspectives on better use of patient-reported outcome measures in head and neck cancer

Update on a Model to Minimize Population Health Loss in Times of Scarce Surgical Capacity During the COVID-19 Crisis and Beyond

The ICEpop Capability Measure for Adults Instrument for Capabilities

Good days and bad days

Minimizing population health loss in times of scarce surgical capacity during the Coronavirus disease 2019 crisis and beyond

Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands

Quantification of trauma center access using geographical information system-based technology

Development of a Patient-Reported Outcome Measure for Geriatric Care: The Older Persons and Informal Caregivers Survey Short Form

END-OF-LIFE CARE IN PATIENTS WITH METASTATIC CUTANEOUS MELANOMA IN THE NETHERLANDS

HEALTHCARE COSTS OF IPILIMUMAB IN PATIENTS WITH ADVANCED CUTANEOUS MELANOMA IN DUTCH CLINICAL PRACTICE

HEALTH VALUATION OF DIALYSIS WITH THE EQ-5D: DETERMINANTS OF DISCREPANCY BETWEEN PATIENTS AND SOCIETY

SECOND-LINE TREATMENT FOR STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE WITH MESENCHYMAL STROMAL CELLS. A CONCEPTUAL DISEASE MODEL

MAPPING ACROQOL SCORES TO EQ-5D TO OBTAIN UTILITY VALUES FOR PATIENTS WITH ACROMEGALY

LONG-TERM IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION OVER 4 YEARS OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

LONG-TERM IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION OVER 4 YEARS OF CERTOLIZUMAB PEGOL TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS, WITH AND WITHOUT PRIOR ANTI-TNF EXPOSURE

Comprehensively Measuring Health-Related Subjective Well-Being: Dimensionality Analysis for Improved Outcome Assessment in Health Economics

CLINICAL RESPONSES IN JOINT AND SKIN OUTCOMES AND PATIENT-REPORTED OUTCOMES ARE ASSOCIATED WITH INCREASED PRODUCTIVITY IN THE WORKPLACE AND AT HOME IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL

DEVELOPMENT OF A CONCEPTUAL MODEL FOR EARLY HEALTH TECHNOLOGY ASSESSMENT OF TISSUE-ENGINEERED HEART VALVES

CLINICAL RESPONSES AND IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES ARE ASSOCIATED WITH INCREASED PRODUCTIVITY IN THE WORKPLACE AND AT HOME IN AXIAL SPONDYLOARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL

Calculating Preference Weights for the Labor and Delivery Index: A Discrete Choice Experiment on Women's Birth Experiences

Mapping the Clinical Chronic Obstructive Pulmonary Disease Questionnaire onto Generic Preference-Based EQ-5D Values

SUSTAINED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION WITH CERTOLIZUMAB PEGOL OVER 96 WEEKS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

SUSTAINED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY AND SOCIAL PARTICIPATION WITH CERTOLIZUMAB PEGOL OVER 96 WEEKS IN PATIENTS WITH PSORIATIC ARTHRITIS

COST-EFFECTIVENESS OF A COPD DISEASE MANAGEMENT PROGRAM IN PRIMARY CARE: THE RECODE CLUSTER RANDOMIZED TRIAL